Anti-Lipoprotein Lipase Antibodies in Patients with Hypertriglyceridemia without Associated Autoimmune Disease
Carregando...
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
ISRAEL MEDICAL ASSOC JOURNAL
Citação
ISRAEL MEDICAL ASSOCIATION JOURNAL, v.13, n.6, p.350-353, 2011
Resumo
Background: Anti-lipoprotein lipase antibodies have been described in rare cases of patients with hypertriglyceridemia. However, no systematic study evaluating these antibodies in patients with this lipid abnormality has been undertaken. Objectives: To analyze the correlation of anti-lipoprotein lipase (anti-LPL) antibodies with other laboratory findings in patients with hypertriglyceridemia but no autoimmune disease. Methods: We evaluated 44 hypertriglyceridemic patients without autoimmune disease. Clinical and laboratory evaluations included analyses of comorbidities, fasting lipid profile and anti-LPL antibodies. Results: Mean patient age was 55 +/- 10 years; 46% of the patients were female and 64% were Caucasian. The mean disease duration was 94.4 months and mean body mass index 28.7 +/- 3.6 kg/m(2); 34.0% were diabetic, 25.0% were obese, 72.7% had systemic arterial hypertension, 75% were sedentary, 15.9% were smokers, 56.8% had a family history of dyslipidemia, 45.5% had a family history of coronary insufficiency, 20.5% had acute myocardial infarction, 9.0% had undergone revascularization and 11.0% angioplasty, 79.5% were being treated with statins and 43.2% were taking fibrates. Median triglyceride levels were 254 mg/dl (range 100-3781 mg/dl), and total cholesterol level was 233 +/- 111 mg/dl. High-density lipoprotein was 42.6 +/- 15.4 mg/dl, low-density lipoprotein 110.7 +/- 42.4 mg/dl and very low-density lipoprotein 48 +/- 15 mg/dl. Anti-LPL antibodies were identified in 2 patients (4.5%), both of whom had a family history of dyslipidemia, coronary insufficiency and acute myocardial infarction; one had undergone myocardial revascularization and percutaneous transluminal coronary angioplasty, and both were using fibrates and had normal triglyceride levels. Conclusions: Our findings demonstrate a correlation between the immune response and dyslipoproteinemia in hypertriglyceridemic patients, suggesting that autoimmune disease contributes to the dyslipidemia process.
Palavras-chave
lipoprotein lipase, anti-lipoprotein lipase, atherosclerosis, hypertriglyceridemia, dyslipidemia
Referências
- KORN ED, 1955, J BIOL CHEM, V215, P1
- SIEDEL J, 1983, CLIN CHEM, V29, P1075
- Yadav D, 2003, J CLIN GASTROENTEROL, V36, P54, DOI 10.1097/00004836-200301000-00016
- FOSSATI P, 1982, CLIN CHEM, V28, P2077
- BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P326
- BEAUMONT JL, 1977, ATHEROSCLEROSIS, V26, P67, DOI 10.1016/0021-9150(77)90141-1
- BEAUMONT J-L, 1970, Revue Europeenne d'Etudes Cliniques et Biologiques, V15, P1037
- CARVALHO JF, 2009, REV BRAS REUMATOL, V49, P670
- DECARVALHO B, 2004, ARTHRITIS RHEUM, V50, P3610
- de Carvalho JF, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/803409
- de Souza AWS, 2007, LUPUS, V16, P782, DOI 10.1177/0961203307081847
- FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499
- GLUECK CJ, 1969, AM J MED, V47, P318, DOI 10.1016/0002-9343(69)90158-2
- KIHARA S, 1989, NEW ENGL J MED, V320, P1255, DOI 10.1056/NEJM198905113201906
- Kodera M, 2005, J RHEUMATOL, V32, P629
- Okamoto Y, 1995, J Atheroscler Thromb, V2, P66
- PAUCIULLO P, 1986, J ENDOCRINOL INVEST, V9, P517
- Pruneta V, 1997, J CLIN ENDOCR METAB, V82, P791, DOI 10.1210/jc.82.3.791
- Pruneta-Deloche V, 2005, J CLIN ENDOCR METAB, V90, P3995, DOI 10.1210/jc.2005.0205
- Reichlin M, 2002, ARTHRITIS RHEUM, V46, P2957, DOI 10.1002/art.10624
- WARNICK GR, 1979, CLIN CHEM, V25, P596
- Yoshimura T, 1998, EUR J OBSTET GYN R B, V76, P49, DOI 10.1016/S0301-2115(97)00154-1